Reza Fahlevi, Eka Laksmi Hidayati, Pricilla Gunawan
Objective: Renal replacement therapy (RRT) is the main therapy in managing pediatric patient with end stage renal disease (ESRD). There are three modalities of RRT including hemodialysis (HD), continuous ambulatory peritoneal dialysis (CAPD), and renal transplantation (RT). This research is aimed to present the profile and RRT modality of pediatric ESRD patient. Methods: Retrospective data including patients’ sex, age at diagnosis, underlying disease, RRT modality was obtained from electronic medical record of pediatric ESRD patients in Cipto Mangukusumo Hospital from January 2014 to October 2017. Result: During January 2014 to October 2017 there were 61 pediatric ESRD patient, 39 patients were male. The mean age at ESRD diagnosis was 14.9-year-old. Etiology of ESRD was nephrotic syndrome (37,7%), congenital anomaly of the kidney and the urinary tract (32,8%), lupus nephritis (11,5%), and other (26,2%). All patients had HD as initial RRT modality before converted to other RRT modalities. After conversion based on patient’s preference, RRT modality in pediatric ESRD patient were HD (44,3%), CAPD (39,2), and RT (16,4%). During this period, the mortality rate among pediatric ESRD patients was 14,7%, most of whom were from HD group (n=7) and other from RT group (n=2). Conclusion: Nephrotic syndrome is the most prevalence etiology of ESRD in pediatric patient. Hemodialysis is still the main RRT modality in pediatric ESRD patient. However, more than 50% patient already had CAPD or RT modality. More effort and concern are needed to increase the CAPD and RT rate among pediatric ESRD patient to have better outcome in the future.